Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLITENS: T-PTNS vs Solifenacin for Hyperactive Bladder
NCT03468465Phase 4Unknown
- Sponsor
- Fundación para la Formación e Investigación Sanitaria
- Start
- May 2018
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Fundación para la Formación e Investigación Sanitaria. Primary endpoints: Episodes of urgency at 12 weeks, Urinary frequency at 12 weeks and 3 more. Status: unknown.
Beyond the preview
Go deeper on NCT03468465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03468465.